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Abstract 
 
 
Background 
 
An abdominal aortic aneurysm (AAA) is an abnormal widening of the 
aorta with a risk of rupture if it grows to a large diameter. Rupture is 
associated with massive bleeding and a poor prognosis for survival.  
 
Aims 
 
The aim of this thesis was to evaluate the results of surgical intervention 
in patients with AAAs detected by population-based screening, including 
comparisons with the results in patients with aneurysms that were not 
detected by screening. A further aim was to investigate how common 
misdiagnosis is in the emergency department in patients seeking care for 
a ruptured AAA (rAAA), and how misdiagnosis affects the prognosis. A 
third aim was to investigate whether it is beneficial to treat patients with 
a primary open abdomen with delayed closure after open repair for 
rAAA.  
 
Methods 
 
Patients with AAA were identified in the Swedish Vascular Registry 
(Studies 1‒4) and the Swedish Cause of Death Registry (Study 4). 
Additional information was obtained through review of medical charts 
(Studies 2‒4). In Study 1, mortality, complications, and method of 
surgical intervention were compared in patients with AAAs detected by 
screening and in age-matched controls with AAAs that were not detected 
by screening. In Study 2 and Study 4, the outcome in patients with a 
ruptured abdominal aortic aneurysm (rAAA) who were misdiagnosed at 
the first assessment in the emergency department was compared to the 
outcome in patients who were correctly diagnosed initially. Study 2 
included patients who reached surgery and Study 4 included all patients 
with rAAA, whether or not they reached surgery. In Study 3, mortality 
5
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and complications in patients treated with a primary open abdomen after 
open repair for rAAA were compared to a propensity score-matched 
control group in which the majority of patients had the abdomen closed at 
the end of the procedure. 
 
Results  
 
Study 1: A higher proportion of the screening-detected patients were 
treated with open repair (56% vs. 45% in those with AAAs not detected 
by screening). The mortality 30 days, 90 days, and 1 year after open 
repair was similar in patients with screening detected and non screening- 
detected aneurysms. Mortality at 30 days and 1 year after Endovascular 
Aortic Repair (EVAR) was similar in both groups. Mortality at 90 days 
after EVAR was lower in the screening-detected compared to the non 
screening-detected patients (0% vs. 3.1%; p = 0.04). The overall 30-day 
mortality (including patients treated with either open repair or EVAR) 
was 0.6% in screening-detected patients and 1.4% in non screening-
detected patients. (p = 0.45). The adjusted odds ratio for the primary 
endpoint (mortality or major complication at 30 days) was 1.64 (95% CI  
0.82‒3.25) in non screening-detected patients. 
 
Studies 2 and 4: Misdiagnosis was common and occurred in more than 
one-third of the patients with rAAA. Overall, the mortality was 74.6% in 
misdiagnosed patients and 62.9% in correctly diagnosed patients (p = 
0.01). The adjusted odds ratio for mortality in the whole cohort of 
misdiagnosed patients was 1.83 (1.13‒2.96). In patients who reached 
surgery, there was no significant difference in mortality between 
misdiagnosed patients and correctly diagnosed patients.  
 
Study 3: There were no significant differences in mortality or major 
complications between patients treated with a primary open abdomen 
with delayed closure and patients treated with primary closure of the 
abdomen. 
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Conclusion 
 
The contemporary mortality after AAA surgery in Sweden was low 
irrespective of whether or not screening was used for detection. Patients 
with AAAs detected by screening had the same comorbidities and 
outcome as those with non screening-detected aneurysms, except for 90-
day mortality after EVAR, which was lower in the screening group. 
 
Misdiagnosis is common in patients who seek care for a rAAA, and 
misdiagnosis is associated with a substantially higher risk of dying from 
the ruptured aneurysm.  
 
No survival advantage and no lower frequency of complications was 
observed in patients treated with a primary open abdomen and delayed 
closure after open repair for rAAA as compared to a propensity score-
matched control group where the majority of patients were treated with 
primary closure of the abdomen.
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Sammanfattning på svenska 
Bukaortaaneurysm (även benämnt Abdominellt Aorta Aneurysm eller 
AAA) innebär att den del av kroppspulsådern (aorta) som är belägen i 
buken har utvidgat sig på ett onormalt sätt. Sjukdomen är förhållandevis 
vanlig och förekommer hos omkring 1,5 % av Sveriges 65-åriga män. 
Hos kvinnor är bukaortaaneurysm betydligt mer sällan förekommande. 
Den principiella faran med ett bukaortaaneurysm är att det finns en risk 
för att det brister. Denna risk är mycket låg om aneurysmet är litet, men 
ju större aneurysmet är, desto större blir risken att det brister. Ett brustet 
bukaortaaneurysm är ett mycket allvarligt tillstånd förenat med massiv 
blödning. Majoriteten av de människor som drabbas av ett brustet 
bukaortaaneurysm överlever inte, men det finns en chans att överleva vid 
snabb kirurgisk behandling. Dödligheten är tyvärr hög även hos patienter 
som snabbt kommer till kirurgisk behandling, men utan sådan är det inte 
möjligt att överleva ett brustet bukaortaaneurysm. Vid upptäckt av ett 
större bukaortaaneurysm innan det brister kan det finnas möjlighet till 
kirurgisk behandling med en låg dödlighet. Därav är det en klar fördel att 
diagnosticera ett bukaortaaneurysm innan de brister. Screening av 65-
åriga män med ultraljud erbjuds i hela Sverige. Syftet med screeningen är 
att påvisa bukaortaaneurysm och ge möjlighet till planerad behandling 
om aneurysmet är eller blir så stort att risken för att det brister är hög. 
 
I denna avhandling studeras sjukdomen bukaortaaneurysm ur tre olika 
synvinklar.  I Studie 1 utvärderas resultatet av kirurgisk behandling hos 
patienter där man funnit ett bukaortaaneurysm i samband med screening. 
Resultaten hos denna patientgrupp jämförs med resultatet hos de 
patienter där man funnit ett bukaortaaneurysm på något annat sätt än 
inom ramen för screening programmet. Studien visar att dödligheten efter 
kirurgisk behandling är låg hos såväl patienter med bukaortaaneurysm 
som upptäckts vid screening som hos patienter med bukaortaaneurysm 
som upptäckts på andra sätt. Mortaliteten var lägre 90 dagar efter 
operationen hos patienter med screeningupptäckta aneurysm, i övrigt 
påvisades inga avgörande skillnader i resultatet efter kirurgisk behandling 
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mellan de två grupperna.  
 
I Studie 2 och 4 undersöks hur ofta patienter som insjuknat med ett 
brustet bukaortaaneurysm blir felbedömda på akutmottagningen och hur 
detta påverkar möjligheterna att överleva. Det undersöks även hur en 
initial felbedömning på akutmottagningen påverkar förekomsten av 
allvarliga komplikationer hos de patienter som når kirurgisk behandling. I 
båda studierna så blev mer än en tredjedel av patienterna felbedömda i 
samband med den första undersökningen av läkare på akutmottagningen. 
Patienter som blev felbedömda löpte en avsevärt större risk att dö än 
patienter där man misstänkte eller säkerställde brustet bukaortaaneurysm 
redan vid den första undersökningen. Hos patienter där man efter en 
första felbedömning sedermera i akutskedet kunde konstatera ett brustet 
bukaortaaneurysm, och behandla tillståndet kirurgiskt, hade inte sämre 
chanser att överleva än patienter som fick rätt diagnos direkt.  
 
I Studie 3 undersöks huruvida det är gynnsamt att lämna buken öppen 
med ett specialanpassat vakuumförband, och sluta buken i ett något 
senare skede, hos patienter som opererats med öppen teknik för ett 
brustet bukaortaaneurysm. Skälet till att göra detta skulle vara att undvika 
att ett högt tryck utvecklas i bukhålan efter operationen till följd av 
blödningen och svullnad av organ och vävnad i bukhålan.  Det är känt att 
om trycket i bukhålan blir påtagligt högt så påverkas viktiga 
kroppsfunktioner såsom blodcirkulation, andning och njurfunktion, och 
möjligheten att överleva och återhämta sig försämras.  Patienter som 
behandlats med öppen buk i initialskedet efter en öppen operation för 
brustet bukaortaaneurysm jämfördes med en patientgrupp där man i 
flertalet av fallen hade stängt buken vid operationens slut. Studien kunde 
inte påvisa någon skillnad i dödlighet eller förekomst av allvarliga 
komplikationer mellan patienter som behandlats med öppen buk initialt 
och kontrollgruppen.  
 
Sammanfattningsvis så konstaterades i denna avhandling att mortaliteten 
är låg vid planerad kirurgisk behandling av bukaortaaneurysm i Sverige 
idag. Resultaten 30 dagar efter operationen var likvärdiga hos patienter 
med screeningupptäckta och icke screeningupptäckta aneurysm.  
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Det konstaterades även att det är vanligt förekommande att patienter som 
söker vård för ett brustet bukaortaaneurysm blir felbedömda på 
akutmottagningen och att detta är förenat med en klart ökad risk att inte 
överleva. 
 
Ingen fördel med att behandla patienter som opererats med öppen teknik 
för ett brustet bukaortaaneurysm med öppen buk i initialskedet efter 
operationen kunde påvisas, när sådan behandling jämfördes med en 
patientgrupp där man slutit buken vid operationens slut i merparten av 
fallen.  
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Introduction and background 
Abdominal aortic aneurysms  
 
An aneurysm is a localized widening of an artery or vein. Thus, an 
abdominal aortic aneurysm (AAA) is a localized abnormal widening of 
the abdominal aorta. The aorta is the largest artery of the human body.  
 
AAAs with large diameters have a risk of rupture, a dramatic event 
accompanied by massive bleeding and a poor prognosis for survival. 
 
The ultimate goal of research on AAA is to reduce the risk of dying from 
a ruptured AAA (rAAA).  
 
This thesis focus on three different steps in the chain of care of 
individuals with AAAs: (1) screening in order to find AAAs before 
rupture, (2) the assessment of patients with rAAA who seek care in an 
emergency department (ED), and (3) whether it is beneficial to treat 
patients operated with open surgical repair of an AAA with an open 
abdomen regimen initially after the procedure. 
 
 
Definition 
 
The term aneurysm originates from an ancient Greek word meaning 
dilatation. An aortic aneurysm is a dilatation of the aorta including all 
layers in the vessel wall (intima, media, and adventitia). There are 
various definitions of AAA. The most common and generally used 
definition is the one proposed by McGregor in 1975, that an aneurysm is 
an infrarenal aortic diameter of 30 mm or larger1. This definition is based 
on previous work by Steinberg and Stein, who reported 200 cases of 
17
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abdominal aortic aneurysm diagnosed by aortography2 and work by 
Leopold et al, who reported on ultrasonic abdominal aortography in 
19703. Another definition of AAA is that it is a ratio between the 
diameter of the infrarenal and suprarenal aorta > 1.54,5.  The lack of a 
uniform definition of AAA is a weakness of epidemiological studies on 
AAA. It has been demonstrated that varying definitions of rAAA 
influence the reported prevalence of the disease6. 
Abdominal aortic aneurysms are located between the 
diaphragm and the aortic bifurcation. A weakening 
of the aortic wall causes dilatation of the aorta. The 
most common location of an aortic aneurysm is 
below the renal arteries (infrarenal aneurysm)7.  
Juxtarenal aneurysms begin immediately below the 
renal arteries, pararenal aneurysms involve the renal 
arteries, and suprarenal aneurysms involve one or 
more visceral arteries. AAAs can be treated 
surgically by either open repair (OR) or 
endovascular aortic repair (EVAR). The more 
cranially an AAA is located, the more demanding is 
the surgical or endovascular repair. 
 
The natural course of an aneurysm is generally a 
progressive expansion over a number of years, but 
the growth rate can vary considerably between 
individuals.  The diameter of a normal abdominal aorta has been reported 
to be 16.8 ± 2.9 mm in men over 50 years and 14.6 ± 1.9 mm in women 
of the same age8. However, the diameter of the aorta varies according to 
age, sex, and body surface area, and population-based normative values 
are available9. 
???????????????
?????????????????
?????????????????
????????????????
??????????????????
???????????????????? 
18
Abdominal	  Aortic	  Aneurysm	  
17	  	  
Historical aspects 
 
The first written evidence of aneurysms has been found in the Ebers 
papyri from ancient Egypt, dating back to 1550 BC 10.  Aneurysms were 
also described as “Sira Granthi” or tumour of blood vessels in the Indian 
medical text Suhruta Samhita, around 600‒800 BC11.  Various attempts 
to treat abdominal aortic aneurysms have been made historically, 
including attempts to ligate the aneurysm, which was practised by the 
Greek surgeon Antyllus as early as 126‒216 AD 12. Ligation continued to 
be an option for surgical treatment of aneurysmal disease and was 
reported in 1817, when Mr Cooper ligated the aorta on a young man with 
an iliac aneurysm, who died shortly after the procedure13. 
  
A successful attempt to ligate an aneurysm was reported by Dr Matas in 
1923, when a syphilitic aortoiliac aneurysm in a 22-year-old woman was 
ligated. Despite several surgical complications, she survived the 
procedure and died from a haemorrhage from a bleeding pulmonary 
tubercular cavity 17 months after the procedure14. 
  
Other―mostly fatal―attempts to treat AAAs were also reported in the 
middle of the twentieth century, including methods of inducing 
thrombosis of the aneurysm by introducing thin wires through which the 
blood in the aneurysm was heated to 80°C 15. 
 
Wrapping of AAAs in cellophane has been tried, to induce fibrosis and 
reduce expansion and the risk of rupture. Albert Einstein was treated with 
this method in 1948. His aneurysm ruptured 6 years later and he then 
refused any further surgical attempts16. Attempts to restore a tubular 
lumen by arteriorraphy have also been reported17. 
 
A major drawback of ligation of the aorta or deliberate induction of 
thrombosis of an aortic aneurysm is naturally the risk of severe ischaemia 
of the lower parts of the body that is accompanied by such a procedure.  
In 1951, Freeman et al. reported the first successful procedures for 
abdominal aortic aneurysms, in which the blood flow through the aorta 
19
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was preserved by using an autologous vein (the iliac vein or internal 
jugular vein)18. In 1951‒1952, Dubost described AAA resection with 
preservation of blood flow by using a preserved human arterial graft19. A 
couple of years later (1954), Schumacker et al. reported on the use of 
artificial grafts for bypass in the treatment of AAAs20, a method that has 
been used in numerous patients since then, and still is. 
 
The Ukrainian surgeon Nicholas Volodos contributed a major step in 
vascular surgery by reporting on endovascular treatment of AAAs in 
198621. However, it was a later publication in English by Juan Carlos 
Parodi in 1991 that was responsible for the introduction of EVAR 
throughout the world22. 
 
 
Pathophysiology 
 
The pathophysiological basis of AAA formation is complex and 
multifactorial. It was previously believed that aneurysm formation was a 
manifestation of atherosclerosis. It is now known that the 
pathophysiology of AAA formation involves a degenerative process 
involving the arterial wall. It has been suggested that localized 
haemodynamic stress, fragmented proteins in the tunica media, genetic 
predisposition, and unknown factors lead to attraction of inflammatory 
cells to the arterial wall. Chemokines, cytokines, and reactive oxygen 
species are released―with a resulting further influx of leukocytes and 
activation of proteases, including matrix metalloproteases (MMPs). This 
results in degradation and remodelling of the aortic wall, further 
dilatation, and aneurysm formation23.  
 
It is known that aneurysms of the common and internal iliac artery may 
occur simultaneously with AAAs24. However, aneurysms of the external 
iliac arteries are very rare25, suggesting that embryological factors may 
also play a role in the pathogenesis of aneurysms26. 
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Epidemiology 
 
The prevalence of abdominal aortic aneurysms has declined in recent 
years in many parts of the world, but not all. Western Europe, North 
America, and Australasia have had the most pronounced decline, while 
Oceania, tropical Latin America, sub-Saharan Africa, and Central Asia 
showed an increase in the prevalence of AAA between 1990 and 201027.  
The prevalence of AAA was reported to be 2.2% in 65-year-old men in 
Sweden in 201128, as compared to 3.5‒5.7% in men < 70 years of age in 
earlier reports from screening studies performed in the United Kingdom, 
Denmark, and Australia 29. The Swedish prevalence was even lower in a 
report by Wanhainen et al.  from 2016, with a prevalence of AAA of 
1.5% in 65-year-old men30. 
  
It has been proposed that the declining incidence can be explained by 
declining smoking in the population28,31-33. AAA is around 4‒6 times 
more common in men than in women34-36.  In a Swedish study from 2013, 
the prevalence of AAA in 70-year-old women was 0.5%37. 
 
Despite the declining prevalence of the disease in some parts of the 
world, ruptured abdominal aortic aneurysms (rAAAs) have an estimated 
global annual mortality rate of 150,000 individuals38.  
 
 
 
Risk factors 
 
Several risk factors associated with the development of AAA, expansion, 
and rupture have been studied, including age, sex, a family history, 
smoking, hypertension, diabetes mellitus, obesity, hyperlipidaemia, 
alcohol consumption, and physical activity. 
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Age 
 
AAA is predominantly a disease of the elderly; it is uncommon in 
younger people. Advancing age is a risk factor that has been reported in 
several studies39-43. A large study in the United States, including 3.6 
million self-referred individuals who paid for vascular screening, 
examined the prevalence of AAA at different ages. The cohort studied 
consisted of 64% women and 36% men. The prevalence of AAA in 
asymptomatic individuals was 0.05% in subjects aged 40‒50 years, 
0.22% in those aged 51‒60 years, 0.84% in those aged 61‒70 years, 
1.73% at 71‒80 years, 2.55% at 81‒90 years and 3.35% at 91‒100 
years44. The authors did not report gender-specific prevalence.   
 
 
Sex 
 
Male gender is a risk factor for AAA. The prevalence of AAA in men is 
4‒6 times greater than that in women34-37,39-43 
 
The reason for the higher prevalence of AAAs in men is poorly 
understood. The possibility of genetic predisposition in men is obvious, 
but environmental factors such as smoking habits probably also 
contribute to the difference in prevalence. Mouse models have indicated 
that androgens have a role in the development of AAAs 45,46. Animal 
models in recent publications have also indicated that the androgen 
receptor may have an important role in aneurysm formation47,48.  
 
 
Smoking 
 
Smoking is the strongest risk factor for AAA34,36,39-43,49 (OR > 3.0 in all 
studies). The association between smoking and AAA is stronger than 
between smoking and other forms of cardiovascular disease50. Only lung 
cancer and chronic obstructive pulmonary disease have a stronger 
epidemiological association with smoking than AAA 51.   
 
The association between smoking and AAA has been reported to increase 
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significantly with the number of years of smoking and to decrease 
significantly with the number of years after stopping smoking41. Smoking 
is also associated with an increased expansion rate52,53. 
 
Family history 
 
A family history is a known risk factor for AAA. In a Swedish study, the 
risk of developing AAA was approximately twice as much in individuals 
with a first-degree relative who has been diagnosed with AAA (compared 
to individuals with no family history)54. In a meta-analysis, first-degree 
relatives of patients with AAA were also found to be significantly more 
affected by AAA, indicating that the disease has a genetic basis55. 
However, the genetic background of the disease has not been studied 
completely, and many questions on the genetics of AAA remain to be 
answered. 
 
Other risk factors 
 
Hypertension, hypercholesterolaemia, other vascular disease, and greater 
height have also been suggested to be risk factors for the development of 
AAA, but with less solid evidence than the risk factors mentioned 
above56. Black or Asian race and diabetes mellitus have shown a negative 
association with the development of AAA56. 
 
 
Risk of rupture and indication for intervention 
 
The risk of rupture is associated with the size of the aneurysm. Small 
aneurysms have a very low risk of rupture, but the larger the aneurysm, 
the greater is the risk of rupture. When the maximum diameter of the 
aneurysm exceeds 5.5 cm, the risk of rupture increases markedly57-59. 
Elective surgical repair of non-ruptured AAAs is associated with a 
mortality of around 1.3‒5.8%60-62. Given the procedure-related risk of 
death and the low risk of rupture and death in small aneurysms, it is not 
beneficial to treat small aneurysms surgically. Two large randomized 
trials comparing ultrasound surveillance of AAAs measuring 4‒5.5 cm 
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and early surgical repair have been published62,63. The studies showed 
that ultrasonographic surveillance for small abdominal aortic aneurysms 
is safe, and that surgery does not provide a long-term survival advantage. 
The results did not support a policy of surgical repair for abdominal 
aortic aneurysms of 4.0–5.5 cm in diameter. It is generally accepted that 
elective AAA repair is indicated in patients who are fit for surgery when 
the maximum diameter of the aneurysm exceeds 5.5 cm. However, it has 
been observed that women have a higher rupture-related mortality than 
men53,64-68, and some authors have advocated a threshold of 5.0 cm for 
elective repair in women. The procedure-related risk is also higher in 
women65,67,69, so patient selection is of importance. 
  
In patients with a ruptured AAA, the mortality rate without surgical 
intervention is 100%. Thus, rupture is an obvious indication for surgery 
in patients who are considered to be fit for such a procedure and who 
have a reasonable chance of surviving both surgical intervention and the 
perioperative period. 
 
 
Clinical presentation 
 
Abdominal aortic aneurysms are usually asymptomatic when they have 
not ruptured, and the sensitivity of abdominal palpation for detection of 
non-ruptured AAAs is reported to be < 70% or even lower in obese 
patients70. Rupture, on the other hand, is a dramatic event accompanied 
by massive bleeding, with an overall mortality previously reported to be 
around 70‒80%71,72. Many patients who suffer from a ruptured abdominal 
aortic aneurysm never reach surgery. Ruptured abdominal aortic 
aneurysms that are not treated with surgical intervention have a mortality 
of 100% and death normally occurs within hours to days. Occasionally, 
in contained retroperitoneal ruptures, death might be postponed several 
weeks.  
 
Sometimes non-ruptured aneurysms can cause symptoms. Abdominal 
pain and back pain are the most common symptoms. Symptoms from an 
aneurysm and tenderness on palpation of the aneurysm are considered to 
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be an indication of a high risk of rupture. Symptomatic aneurysms should 
therefore be repaired as soon as possible.  
The classical clinical picture in patients with ruptured abdominal aortic 
aneurysms is a triad: abdominal pain, hypotension, and a palpable 
pulsatile mass in the abdomen. However, many patients with rAAA do 
not present with the classical triad, and the condition is too often foreseen 
and the patients misdiagnosed73-84. The effect of misdiagnosis on the 
patient’s prognosis is largely unknown. 
 
The mortality in rAAA patients who undergo surgery is only partly 
explained by intraoperative deaths due to uncontrollable bleeding. 
Multiple-organ failure, cardiovascular complications, septicaemia, bowel 
gangrene, and abdominal compartment syndrome are also factors that 
contribute to in-hospital mortality following rAAA repair. 
 
 
Imaging 
 
AAAs and rAAA can be identified with different imaging techniques 
including ultrasound, CT, and MR. Ultrasound is a radiation-free and 
normally contrast-free method that is suitable for screening and detection 
of AAAs. A CT scan is often used to more exactly reveal the anatomy of 
the aneurysm when surgical intervention is considered. 
 
 
Treatment 
 
Medical treatment 
 
Several drugs have been studied in order to find a medical therapy that 
can prevent the development and growth of AAAs. So far, no drug has 
been shown to be beneficial 85,86.  Smoking cessation and adequate 
treatment of hypertension and other cardiovascular risk factors is offered 
to patients with small AAAs. The treatment of larger aneurysms is 
surgical, with two principal surgical techniques available: open repair 
(OR) and endovascular aortic repair (EVAR). 
25
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Surgical treatment 
Open repair 
OR is a surgical procedure where the abdomen is generally opened in the 
midline. 
 
The small intestine is held to the right in the abdominal cavity. The 
retroperitoneum is opened to expose the aneurysm. The aorta is clamped 
above and below the aneurysm to temporarily inhibit blood flow. The 
aneurysm sac is opened and a synthetic graft is sutured to the aorta 
proximally and distal to the aneurysm. The clamps are removed to allow 
blood flow in the graft. The aneurysm walls are wrapped around the 
synthetic graft to protect it and prevent infection and formation of aorto-
enteric fistulae87.  
?????????????????
??????????????????????????????????
?????????????????????????????????
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EVAR 
 
EVAR is performed percutaneously and can be done under local 
anaesthesia if necessary. Punctures in the groins give access to the 
femoral arteries. A covered stent (stent graft) is introduced through the 
femoral and iliac arteries under radiological guidance. The stent graft is 
positioned in order to exclude the aneurysm from the circulation. In 
standard cases with infrarenal aneurysms, the proximal end of the stent 
graft is positioned just below the renal arteries. The placement of a stent 
graft requires sealing zones with normal aorta and iliac vessels above and 
below the aneurysm where the stent graft is anchored. 
 	  
	  
	  
	  
Illustration	  2. 	  	  	  
Endovascular	  aortic	  repair	  (EVAR).	  A	  stent	  graft	  is	  
positioned	  in	  the	  abdominal	  aortic	  aneurysm	  under	  
radiological	  guidance	  in	  order	  to	  exclude	  the	  aneurysm	  
from	  the	  circulation. 
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Outcome of surgical intervention 
 
Elective open repair or EVAR in non-ruptured 
aneurysms 
 
In large, randomized controlled trials comparing open repair and EVAR 
(ACE, DREAM, EVAR 1, OVER), short-term mortality has been 
reported to be 0.6‒4.6% in patients treated with open repair and 0.5‒
1.8% in patients treated with EVAR electively for asymptomatic 
unruptured aneurysms 88-91. The results in the studies were similar. There 
is an initial survival benefit for patients treated with EVAR rather than 
open repair due to a lower 30-day mortality in EVAR patients. The 
benefit of using EVAR disappears within a few years. EVAR patients 
must be monitored with CT or ultrasound for several years or for life, to 
detect potential endoleaks reperfusing the aneurysm sack―with the risk 
of late rupture. Re-interventions required for the treatment of endoleaks 
make the need for reintervention more common in EVAR patients92,93. 
 
In a 15-year follow-up of the EVAR 1 study, the EVAR group had a 
higher mortality (with a hazard ratio of 1.25) than the open-repair group 
beyond 8 years after the procedure, which was mainly attributed to late 
sac ruptures94. 
 
The 30-day mortality in patients treated for intact AAAs reported in the 
Swedish Registry for Vascular Surgery (Swedvasc) in 2016 was 2.4% for 
patients treated with open repair and 1.7% for patients treated with 
EVAR61.  
 
 
Open repair and EVAR in patients with ruptured 
abdominal aortic aneurysms 
 
In patients with ruptured abdominal aortic aneurysms (rAAAs), both 
EVAR and open repair can be performed, depending on the morphology 
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of the aneurysm and the available expertise. Despite the minimally 
invasive nature of EVAR and the possibility of avoiding general 
anaesthesia, randomized controlled trials have failed to demonstrate any 
significant survival benefit in patients with rAAA who are treated with 
EVAR rather than open repair. The short-term mortality reported in these 
randomized trials has been 24‒39.1% in the open repair group and 18‒
36.4% in the EVAR group95-97.   
 
The 30-day mortality in patients treated for ruptured AAAs reported in 
the Swedish Registry for Vascular Surgery (Swedvasc) in 2016 was 26% 
in those treated with open repair and 18% in those treated with EVAR61.  
 
Mortality in patients undergoing surgical intervention for rAAA is only 
partly explained by uncontrollable intraoperative bleeding. 
Cardiopulmonary complications, multiple-organ failure, septicaemia, 
bowel ischaemia, renal failure, extremity ischaemia, cerebrovascular 
complications, and abdominal compartment syndrome are also factors 
that contribute to mortality in patients who have been treated for rAAA.  
 
 
Abdominal compartment syndrome 
 
The abdomen is a closed cavity. The intra-abdominal pressure (IAP) is 
approximately the same as atmospheric pressure in young healthy adults 
in the supine position98, and 5‒7 mmHg in critically ill adults99. An 
increased intra-abdominal pressure above 12 mmHg is called intra-
abdominal hypertension (IAH). APP is the abdominal perfusion 
pressure, which is defined as the mean arterial pressure (MAP) minus 
the IAP. The standard for the measurement of the IAP is through a 
catheter in the urinary bladder.  
 
An abdominal compartment syndrome (ACS) arises if the IAH rises to 
levels at which organ functions are affected. ACS is defined by the 
World Society of the Abdominal Compartment Syndrome (WSACS) as 
a sustained IAP of > 20 mmHg (with or without an APP 
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of < 60 mmHg) that is associated with new organ dysfunction/failure. 
Intra-abdominal hypertension can affect multiple organ systems, causing 
an ACS and multiple-organ failure: 
 
 
The respiratory system 
 
Elevated IAP causes the diaphragm to rise, which leads to a reduced 
intrathoracic volume. Secondary to this, lung capacity and compliance 
are reduced. The pulmonary vascular resistance is increased by the 
elevated intrathoracic pressure, leading to a further reduction in gas 
exchange. In a porcine model, respiratory dysfunction arose when IAP 
exceeded 15 mmHg and respiratory failure worsened with increasing 
IAP100. 
 
The cardiovascular system  
 
Increasing IAP is accompanied by an increased resistance to blood flow 
in the vena cava and portal vein, reducing the venous return to the heart. 
The increased intrathoracic pressure associated with the IAH further 
reduces venous return in the inferior and superior vena cava. The reduced 
preload and an increased afterload associated with the IAP reduce the 
cardiac output101. 
 
Renal dysfunction 
 
The deterioration in renal function associated with ACS is probably 
multifactorial, including an impaired renal perfusion associated with a 
reduced cardiac output and also an increased renal vascular resistance 
due to compression of the kidneys and renal vein, caused by the IAH102.  
The renin-angiotensin system is activated and contributes to oliguria. 
 
Hepatic dysfunction 
 
Increased IAH reduces the mesenteric and hepatic arterial blood flow and 
also the portal flow and hepatic microcirculation102. In a porcine model 
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where the IAH was elevated to 15 mmHg for 24 hours, alanine 
transaminase and alkaline phosphatase levels were elevated and 
histological examination of the liver showed low-grade necrosis103 
 
 
The gastrointestinal tract 
 
ACS causes decreased mucosal blood flow and intestinal ischaemia, 
resulting in bacterial translocation.104 
 
The central nervous system 
 
The intracranial pressure is increased in patients with ACS. It has been 
suggested that this may be due to a functional obstruction of the venous 
outflow from the brain associated with the increased thoracic 
pressure105,106. 
 
 
Abdominal compartment syndrome in patients with rAAA 
 
Incidence and mortality 
 
Given the risk factors for the development of ACS (abdominal surgery, 
hemoperitoneum, acidosis, polytransfusion, hypothermia, shock or 
hypotension, coagulopathy, and age107), it is not surprising that ACS is 
common in patients who are treated for rAAA. 
 
ACS has been reported to occur in 6.9‒20% of patients treated for rAAA 
with EVAR and 6.8‒34% of patients treated for rAAA with open 
repair108-113. An IAP of > 20 mmHg (with or without a manifest ACS) has 
been reported to occur in about half of all patients who are treated with 
open repair for rAAA114. 
 
The development of ACS is associated with a poor prognosis in patients 
treated for rAAA. Mayer et al. reported 30% mortality in patients treated 
with EVAR for rAAA who developed ACS as compared to 8% in 
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patients who did not develop ACS110. In a study by Pecoraro et al., 
mortality in patients with ACS after open repair for rAAA was 71%, as 
compared to 23% in those who did not develop ACS115. In a population-
based Swedish study by Ersryd et al., mortality in patients treated with 
EVAR or open repair for rAAA was 42.4% in those with ACS and 23.5% 
in those without ACS108. 
 
In a study of patients treated for rAAA with either EVAR or open repair, 
by Sörelius et al., the mortality in patients who needed decompression for 
ACS was 62%, as compared to 29% in patients who did not develop 
ACS116. 
 
ACS occurs more seldom in patients who are treated for intact AAAs 
(iAAAs): in 0.4‒0.5% of patients treated with EVAR and in 0.9‒1.6% of 
patients treated with open repair108,116. When ACS occurs after surgical 
intervention for iAAA, the mortality has been reported to be as high as 
11.5% (as compared to 1.8% in those who did not develop ACS108). 
 
Treatment 
Several medical and non-invasive treatments have been proposed for the 
treatment of ACS, including sedation/analgesia, neuromuscular blockade, 
nasogastric/colonic decompression, promotility agents, and avoidance of 
positive cumulative fluid balance. However, decompressive laparotomy 
should be performed in cases of overt ACS according to current 
guidelines107. 
 
The potential benefit of avoiding the possibility of development of ACS 
by leaving the abdomen open with a vacuum-assisted wound closure 
system and delayed closure has not been studied thoroughly. 
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Illustration of massive swelling of the abdominal viscera in a patient treated with 
open repair for a ruptured abdominal aortic aneurysm. The abdomen was left open 
with a vacuum-assisted closure dressing to avoid development of an abdominal 
compartment syndrome.  
 
 
Screening 
AAAs are generally asymptomatic before rupture. Elective repair of 
intact AAAs is associated with a relatively low mortality (the 
contemporary 30-day mortality after elective surgical intervention is 
approximately 2.0% in Sweden)61 while rupture is associated with a total 
mortality reported to be 68-85%71,72,117. Thus, it is beneficial to detect 
aneurysms before rupture. AAAs can easily be detected with 
ultrasonography. These considerations would suggest that AAA is a 
disease suitable for screening. In fact, AAA fulfils all the classic criteria 
for screening proposed by Wilson and Jungner118. 
 
Accordingly, screening for AAA has been studied thoroughly. Four 
randomized controlled studies of population screening for rAAA were 
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performed in the 1990s: the Chichester trial in the UK119, the Viborg trial 
in Denmark120, the Multicentre Aneurysm Screening Study (MASS) in 
the UK121, and the Western Australia trial122. Early results showed a 
reduction in aneurysm-related mortality of approximately 40% in men 
who were invited to screening. Long-term results are now available for 
all four studies, and a meta-analysis by Takagi et al. of the late results of 
all trials was recently published123. It shows that inviting men for AAA 
screening reduces AAA-related deaths (OR 0.66, 95% CI 0.47‒0.93; p = 
0.02), with a greater effect on men who attend the program (OR 0.40, 
95% CI  0.31‒0.51; p < 0.00001. It was also found that screening reduced 
all-cause mortality in invited men (HR 0.98, 95% CI 0.96‒0.99; p = 
0.003).  
 
The evidence base for population-based screening of AAA in elderly men 
is solid, and population screening of 65-year-old men has been started in 
Sweden and now has nationwide coverage. The outcome of the Swedish 
screening program has been reported by Wanhainen et al30. The 
prevalence of AAA was found to be 1.5% and the number needed to be 
screened to prevent one premature death from AAA was 667. It was 
predicted that the screening programme prevents 90 premature deaths 
from AAA annually in Sweden. 
 
The results of surgical intervention in patients with screening-detected 
aneurysms (compared to the previous standard vascular surgery patient 
with an AAA that was not detected by screening) have not been studied 
thoroughly. 
 
 
AAA screening in women 
 
Only one of the randomized studies 119 included women. Given the low 
prevalence of AAA and the low incidence of rupture in women, it was 
concluded that screening of women would be unlikely to affect the 
outcome of the disease significantly. In a Swedish screening study 
investigating the prevalence of AAA in 70-year-old women, the 
prevalence was found to be 0.5%37. A strong correlation was seen 
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between smoking and AAA. In women who had never smoked, the 
prevalence of AAA was as low as 0.03%. It was concluded that screening 
of non-smoking women would be futile, ruling out population-based 
screening in women. There is no current evidence to support population-
based screening of women for AAA. 
5
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AIMS 
Overall aim 
To investigate possible ways to reduce mortality from ruptured 
abdominal aortic aneurysms. 
Specific aims 
•  To compare the postoperative outcome in patients treated for 
abdominal aortic aneurysms that were detected by screening with 
that in patients treated for aneurysms that were not detected by 
screening, in a population-based setting (Study 1).  
•  To investigate the frequency of misdiagnosis of ruptured 
abdominal aortic aneurysms in the emergency department and 
how misdiagnosis affects the prognosis in terms of mortality and 
complications (Studies 2 and 4). 
•  To investigate whether it is beneficial to treat patients operated 
with open repair for a ruptured abdominal aortic aneurysm with a 
primary open abdomen and delayed closure in order to avoid the 
possibility of development of an abdominal compartment 
syndrome, and the increased mortality and rate of complications 
associated with this condition (Study 3). 
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Patients and methods 
Table 1. Overview of study design, number of participants, data 
sources, comparison, and outcome 
 Design n Source Comparison Outcome 
Study 1 Prospective 
cohort study 
700 Swedvasc Detected by screening 
vs. not detected by 
screening 
Mortality and 
complications after 
surgical 
intervention 
Study 2 Retrospective 
cohort study 
261 Swedvasc and 
medical records 
Misdiagnosed vs. 
correctly diagnosed 
Mortality and 
complications after 
surgical 
intervention 
Study 3 Retrospective 
cohort study  
227 Swedvasc and 
medical records 
Primary open abdomen 
treatment vs. primary 
abdominal closure 
 
Mortality and 
complications after 
surgical 
intervention 
Study 4 Retrospective 
cohort study 
 
455 Swedvasc, 
Swedish Cause 
of Death 
Registry, medical 
records 
Misdiagnosed vs. 
correctly diagnosed 
Mortality 
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Sources of data 
 
Swedvasc 
 
All the studies in this thesis used data extracted from Swedvasc. In study 
1, Swedvasc data alone were used, and in Studies 2‒4, Swedvasc data 
were combined with other sources of data. 
 
Swedvasc is the Swedish National Registry for Vascular Surgery. The 
registry was started and is still maintained by the vascular surgery 
profession in Sweden. The registry achieved nationwide coverage in 
1994, including all vascular surgery centres in Sweden. Data are 
registered prospectively, usually by the vascular surgeon performing the 
procedure, but some hospitals have appointed staff to perform 
registrations. Swedvasc has data on vascular procedures including 
individual patient data (age, sex, comorbidities, whether an aneurysm 
was detected by screening) and also procedural, follow-up, and mortality 
data. The registry does not contain any information on patients with 
vascular diseases who have not undergone a vascular procedure. 
Swedvasc is cross-linked to the Swedish Population Registry, making 
mortality data in the registry highly accurate. 
                                                                                                             
An international validation of data registered in Swedvasc was performed 
by two independent validators, M. Venermo (Finland) and T. Lees (UK) 
in 2014. Local hospital records for 2012 from five vascular centres in 
Sweden were crosschecked with data registered in Swedvasc. It was 
checked whether all the procedures performed at the centres were 
registered in Swedvasc (external validity) and whether the data recorded 
in Swedvasc were accurate (internal validity). Regarding AAA 
procedures, the external validity was found to be 98.8% (95% CI 96.9‒
99.5) and the internal validity was 96.2% (95% CI 94.9‒97.2). Four of 
393 AAA procedures registered in the hospital records were not 
registered in Swedvasc. Mortality in these patients was checked, to rule 
out the possibility that the reason they were not registered was a bad 
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outcome. The four patients were all found to be alive in 2014. It was 
concluded that Swedvasc is a highly accurate system of data collection 
for Swedish vascular surgery124. In an earlier (2008) validation study of 
Swedvasc by Troëng et al., the external validity for abdominal aortic 
aneurysm repairs was found to be 93.2%. The study showed no 
significant difference in mortality between registered patients and the 
whole cohort in elective cases. A higher mortality was observed in 
unregistered patients treated with emergency (unplanned) open repair 
than in patients registered in Swedvasc. However, when the unregistered 
cases were added to the registered cases, no significant increase in 
mortality in the whole cohort was observed. It was concluded that the 
external and internal validity of the Swedvasc registry allows confident 
assessment of volumes of―and mortality after―vascular surgery in 
Sweden125. 
 
In conclusion, Swedvasc is a registry that is considered to have a high 
validity, which has been confirmed by external analysis. The Swedish 
Association of Local Authorities and Regions has a grading of the 
Swedish quality registries, giving the registries a certification level. The 
certification level is a rating given to each registry and represents the 
level of development that the registry has reached in terms of analyses, 
inclusion of relevant indicators, coordination with health services, use in 
research, data quality and reporting, coverage rate, technical 
solutions/tools, and so on. There are four certification levels, with 1 being 
the highest. Swedvasc has certification level 1. 
 
Several scientific reports using Swedvasc data have been published, and 
15 PhD theses have used Swedvasc data. 
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The Swedish Cause of Death Registry 
Data from the Swedish Cause of Death Registry were used in Study 4. 
The Cause of Death Registry includes all those who died during one 
calendar year and were registered in Sweden at the time of death. The 
cause of death and disease(s) contributing to the cause of death are 
registered according to the international version of the disease 
classification ICD-10. The Swedish personal identification number of 
deceased persons is included in the registry, allowing cross matching 
with other registries. 
Medical charts 
 
Data extracted through review of medical charts were used in Studies 2‒
4. All medical charts in Västra Götaland Region during the time period of 
the studies in this thesis were electronic, including notes, laboratory data, 
and radiological examinations. Pre-hospital data on patients transported 
with emergency services were also available in the individual patient’s 
charts. In Study 3, medical charts were retrieved from other vascular 
centres by post, for the propensity score-matched control group. 
 
 
 
 
 
 
 
 
40
Abdominal	  Aortic	  Aneurysm	  
39	  	  
Study design, subjects, and endpoints 
 
Study 1 
 
This was a prospective cohort study using prospectively collected data in 
Swedvasc. Men with AAAs detected through population-based screening 
were compared to an age-matched control group consisting of men with 
AAAs that were not detected by screening, for the period May 2010 to 
January 2013. The hypothesis was that men with screening-detected 
aneurysms would have a better outcome after surgical intervention than 
men with aneurysms that were not detected by screening, due to there 
being less comorbidity. The main aim was to compare the postoperative 
outcome after elective surgical intervention in terms of mortality and the 
frequency of complications at 30 days in men with screening-detected 
AAAs and in men with AAAs that were not detected by screening. 
Secondary aims were to compare 90-day and 1-year mortality, 
preoperative comorbidity, and choice of surgical method between the 
groups. The primary endpoint was a combined endpoint consisting of 
mortality, myocardial infarction, stroke, major amputation, bowel 
ischaemia, and renal failure within 30 days after the surgical intervention. 
 
 
Study 2 
 
This study was a retrospective cohort study comparing the outcome in 
patients with rAAA who were misdiagnosed at the first assessment in the 
emergency department with patients who were correctly diagnosed. 
Patients treated with surgical intervention for rAAA in Västra Götaland 
Region in the period 2008‒2014 were identified in Swedvasc. Only 
patients who were correctly diagnosed some time in the chain of care and 
then underwent surgical or endovascular treatment for rAAA were 
included. Prospectively registered baseline data regarding age, sex, 
comorbidities, and type of surgical intervention (open repair or EVAR) 
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were extracted from Swedvasc. The data extracted from Swedvasc were 
combined with data extracted from medical charts, including data 
regarding assessment in the emergency department. Pre-hospital data and 
time parameters were also extracted from the medical charts. 
 
We hypothesized that initially misdiagnosed patients have a higher 
mortality and a higher frequency of complications than patients who are 
correctly diagnosed initially. The aim of the study was to investigate how 
common it is that patients with rAAA are misdiagnosed and how 
misdiagnosis affects the outcome in rAAA patients. The primary 
endpoint was 30-day mortality. Secondary endpoints were 90-day 
mortality, need for ventilator support, need for postoperative 
haemodialysis, days in the intensive care unit (ICU), and length of 
hospital stay. In addition, delay caused by misdiagnosis was recorded. 
 
 
Study 3 
 
This was a retrospective cohort study comparing mortality and 
postoperative complications in patients treated initially with an open 
abdomen and delayed closure after open repair for rAAA with those in a 
propensity score-matched control group where the abdomen was closed 
at the end of the procedure in a majority of the cases. The reason for 
leaving the abdomen open would be to avoid the risk of development of 
an abdominal compartment syndrome (ACS) and the increased mortality 
and morbidity associated with this (as described in the Introduction 
section). For several years, it has been a clinical routine at Sahlgrenska 
University Hospital to leave the abdomen open at the end of open repairs 
for rAAA, except in selected cases with stable patients and limited 
haematomas. This has led to an accumulated list of cases with open 
abdomen treatment, allowing comparison with controls. Propensity score 
matching was used to create a control group from other vascular centres 
in Sweden, using patients registered in Swedvasc. Baseline data 
including age, sex, aneurysm diameter, perioperative bleeding, and 
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comorbidities, and also mortality data, were extracted from Swedvasc. 
Medical records were retrieved and data regarding clamp position 
(suprarenal or infrarenal) and complications were extracted from the 
medical charts. 
 
We hypothesized that open abdomen treatment and delayed closure 
would be associated with a lower mortality and less complications than 
primary closure of the abdomen in patients who undergo open repair for 
rAAA. The aim of the study was to investigate whether leaving the 
abdomen open, with delayed closure, would improve outcome in terms of 
mortality and complications in patients treated for rAAA with open 
repair. The primary endpoint was 30-day mortality. Secondary endpoints 
were 90-day mortality, bowel ischaemia, need for postoperative renal 
replacement therapy, and postoperative bleeding requiring surgery. 
  
 
Study 4 
 
This was a retrospective cohort study comparing mortality in rAAA 
patients who were misdiagnosed in the emergency department with 
patients who were correctly diagnosed. In contrast to Study 2, all patients 
with rAAA seeking treatment in an emergency department in Västra 
Götaland Region were eligible for inclusion, not only patients who 
reached surgical intervention.  Data on patients treated surgically for 
rAAA in Västra Götaland Region in the period 2010‒2015 were 
extracted from Swedvasc and data on patients registered in the Swedish 
Cause of Death Registry with rAAA as the cause of death were also 
extracted. All deaths recorded in the Swedish Cause of Death Registry 
were confirmed by review of the medical records and/or autopsy reports.  
Data regarding the assessment in the emergency department and clinical 
parameters were extracted from the medical records. 
 
We hypothesized that misdiagnosis in the emergency department in 
patients with rAAA would be associated with a higher mortality than in 
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patients who are correctly diagnosed. The aim of the study was to test 
this hypothesis. The endpoint was rAAA-related mortality. 
Statistics 
 
All statistical analysis in this thesis was performed using the Statistical 
Package for the Social Sciences (SPSS; IBM Corp. Armonk, NY, USA). 
SPSS 22.0 was used in study 1 and SPSS 23.0 was used in Studies 2‒4. 
Descriptive statistics for baseline data are presented as mean ± standard 
deviation (SD) or as median and inter-quartile range (IQR). Fisher’s 
exact test was used for inter-group comparisons of dichotomous 
variables. Student´s t-test was used for two-group comparison of means. 
Mann-Whitney U-test was used when assumptions of normality were 
violated. Univariate binary logistic regression analysis and multivariable 
binary logistic regression analysis were used in all studies in order to 
adjust for confounders that could possibly influence the outcome. 
Propensity score matching was used in Study 3. The propensity score was 
based on nearest-neighbour analysis with two controls for each patient. 
The controls were matched with respect to age, gender, perioperative 
blood loss, preoperative unconsciousness, serum creatinine level, and the 
preoperative comorbidities cardiac disease, hypertension, diabetes, 
respiratory disease, and history of a cerebrovascular event.  
 
 
Ethical considerations 
The four studies in this thesis all investigated outcomes after different 
actions and procedures already performed by the healthcare system in 
Sweden. Thus, the studies did not put any patients at risk of physical 
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harm. Review of medical records violates the integrity of individuals to 
some extent. This potential psychological harm was considered to be 
outweighed by the advantage of gaining important knowledge about the 
treatment of abdominal aortic aneurysms. One could argue that it would 
have been unethical to refrain from evaluating the results of a screening 
programme implemented in a particular country (which was done in 
Study 1). It could also be considered unethical not to investigate the 
results of open abdomen treatment after open repair for rAAA (which 
was done in Study 3), given the very limited knowledge and evidence 
that exists on the topic, and the fact that open abdomen treatment has 
been a clinical routine at Sahlgrenska University Hospital for several 
years. The studies in this thesis were considered to be ethically sound. 
Ethical permission for Study 1 was obtained from the regional ethics 
committee in Uppsala (entry no. 2012/282) and ethical permission for 
Studies 2‒4 was obtained from the Regional Ethical Review Board in 
Gothenburg (entry no. 553-14).  
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Results 
Study 1 
Three hundred and fifty operated men with screening-detected AAAs 
were compared to 350 operated controls with AAAs that were not 
detected by screening. There were no significant differences in baseline 
data except that the median age was 2 years older in patients whose 
AAAs were not detected by screening. The rate of postoperative 
complications was low in both patients with screening-detected AAAs 
and patients with AAAs not detected by screening. No significant 
difference in the rate of complications, in mortality at 30 days, and in the 
combined primary endpoint (mortality and major complications at 30 
days) was observed between the two groups when stratified into open 
repair and EVAR (Table 2). Multivariable logistic regression analysis 
adjusted for age and method of intervention showed no increased risk of 
death or major complications in patients with non screening-detected 
aneurysms (OR 1.64, 95% CI 0.82‒3.25).   
There was no difference in 30-day or 1-year mortality between patients 
with screening-detected aneurysms and the age-matched controls with 
aneurysms that were not detected by screening. Mortality at 90 days in 
patients treated with EVAR was higher in control patients than in patients 
whose aneurysms were detected by screening (3.1% vs. 0%; p = 0.04), 
but there was no significant difference between the groups in patients 
treated with open repair. When we included both patients treated with 
open repair and patients treated with EVAR, the 90-day mortality was 
lower in patients with screening-detected aneurysms than in control 
patients (1.1% vs. 3.7%; p = 0.046).  
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Mortality data are presented in Table 3. 
In multivariable logistic regression analysis adjusted for age and method 
of intervention (EVAR or open repair), there was an increased risk of 
death at or before 90 days for patients with aneurysms that were not 
detected by screening (OR 3.31, 95% CI: 1.05‒10.46).  
Open repair was used more frequently in screening-detected patients 
(56%) than in patients whose aneurysms were not detected by screening 
(45%) (p < 0.01) 
Table 2. Comparison of complications 30 days after surgery in screening-
detected AAA patients and in age-matched controls with non screening-
detected AAAs n = 663-700 (varies with outcome due to missing data) 
excluded due to missing data)                   
 
AMI, acute myocardial infarction.  
*Combined endpoint―any of the following: death, AMI, stroke, major amputation, bowel 
ischaemia, renal failure. 
 
 
 
 Open repair EVAR 
Complications 30 
days after surgery 
Screenin
g-
detected 
n (%) 
Non-screening-
detected 
age-matched controls  
n (%) 
p Screening-
detected 
n (%) 
Non-screening-
detected 
age-matched controls 
n (%) 
p 
 186 147  147 183  
Death 2 (1.0) 5 (3.2) 0.25 
0.70 
0 (0) 0 (0) 1.00 
AMI 4 (2.2) 2 (1.4) 0 (0) 2 (1.1) 0.50 
Stroke 
Amputation 
Bowel ischaemia 
Renal failure 
Combined endpoint* 
 
2 (1.1) 
0 (0) 
1 (0.5) 
7 (3.7) 
12 (6.4) 
 
3 (2.0) 
1 (0.7) 
1 (0.7) 
8 (5.4) 
16 (10.6) 
 
0.66 
0.44 
1.00 
0.60 
0.17 
 
1 (0.7) 
0 (0) 
0 (0) 
2 (1.4) 
3 (2.0) 
 
1 (0.5) 
0 (0) 
0 (0) 
5 (2.7) 
7 (3.8) 
 
1.00 
1.00 
1.00 
0.47 
0.52 
 
Abd compartment 
Distal embolization 
Reop. bleeding 
6 (3.2) 
5 (2.7) 
2 (1.1) 
6 (4.1) 
5 (3.4) 
4 (2.7) 
0.77 
0.75 
0.41 
2 (1.4) 
2 (1.4) 
1 (0.7) 
0 (0) 
2 (1.1) 
5 (2.7) 
0.20 
1.00 
0.23 
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Table 3. Mortality after open repair and endovascular aortic repair (EVAR) in 
screening-detected AAA patients and in age-matched control patients in 
whom aneurysms were not detected by screening  
 
 
AAA, abdominal aortic aneurysm. 
 
 
Study 2 
                                                                                                             
Two hundred and sixty-one patients with rAAA were included in the 
study. Eighty-six (33%) were initially misdiagnosed. Baseline data 
showed no significant differences between the groups apart from a higher 
proportion of patients with a first systolic pressure < 90 mmHg in the 
correctly diagnosed group than in the misdiagnosed group (37.0 vs. 
12.8%; p < 0.001). Misdiagnosis caused a median delay until surgical 
treatment of 4.8 hours. There was no significant difference in 30- or 90-
day mortality, rate of complications, length of intensive care, or length of 
hospital stay between misdiagnosed and correctly diagnosed patients 
(Table 4).   
 
Multivariable logistic regression analysis was performed, with 
adjustment for the potential confounders age, sex, open repair/EVAR, 
primary assessment by internist/surgeon, respiratory disease, and 
transportation to secondary hospital. In this analysis, the OR for mortality 
at 30 days was 0.78 (95% CI 0.38‒1.60) in misdiagnosed patients 
compared to correctly diagnosed patients. The adjusted OR for death at 
30 days in women was 2.32 (95% CI: 1.15‒4.67). The multivariable 
logistic regression analysis is shown in Table 5 
Mortality Open repair (n = 352) EVAR (n = 348) All (n = 700) 
 Screening- 
detected 
n (%) 
Non- 
screening-
detected 
n (%) 
 
 
p 
Screening-
detected 
n (%) 
Non- 
screening-
detected 
n (%) 
 
 
p 
Screening-
detected 
n (%) 
Non- 
screening
-detected 
n (%) 
 
 
p 
n 195 157  155 193  350 350  
30-day 2/195 (1.0) 5/157 (3.2) 0.25 0/155 (0) 0/193 (0)  2/350 (0.6) 5/350 (1.4) 0.45 
90-day 4/195 (2.1) 7/157 (4.5) 0.23 0/155 (0)   6/193 (3.1) 0.04 4/350 (1.1) 13/350 (3.7) 0.046 
1-year 7/173 (4.0) 9/155 (5.8) 0.61   2/140 (1.4)   9/191 (4.7) 0.13 9/313 (2.9) 18/346 (5.2) 0.17 
48
Abdominal	  Aortic	  Aneurysm	  
47	  	  
 
 
 
 
Table 4. Mortality, need for postoperative dialysis, days in ventilator, days 
in ICU, length of hospital stay, and proportion of patients who were able to 
return to their own home at discharge 
 
 
 
 
 
*Median (IQR). 
ICU, intensive care unit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Correct 
diagnosis, 
n (%) 
Misdiagnosis, 
n (%) 
p 
30-day mortality 49(28.0) 24(27.9) 1.00 
90-day mortality 57(32.6) 32(37.2) 0.49 
Need for 
postoperative 
haemodialysis 
35(22.0) 16(20.5) 0.87 
Days in ventilator* 1(1-5) 1.5(0-6) 0.90 
Days in ICU* 4(2-11) 3.5(2-9) 0.73 
Length of hospital 
stay, days* 
14(6-32) 14(8-23.5) 0.77 
Discharged to own 
home 
99(56.6) 48(55.8) 1.0 
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Table 5. Mortality at 30 days in patients with a ruptured abdominal aortic 
aneurysm 
 
 
 
OR, odds ratio; CI, confidence interval; OSR, open surgical 
repair; EVAR, endovascular aortic repair; TIA, transient ischaemic attack; 
BP, blood pressure. 
ap-values for the univariate analysis. 
bMultivariate logistic regression analysis adjusted for misdiagnosis/correct 
diagnosis, age, sex, open repair/EVAR, primary assessment by 
internist/surgeon, respiratory disease, and transportation to secondary hospital. 
 OR, crude 
mortality 
at 30 days 
95% CI pa OR, 
adjusted 
mortality 
at 
30 daysb 
95% CI 
Misdiagnosis 1.0 0.56–
1.77 
0.99 0.78 0.38–
1.60 
Age (per year) (missing = 0) 1.05 1.01–
1.09 
0.02 1.05 1.00–
1.10 
Females (missing = 0) 2.07 1.13–
3.80 
0.02 2.32 1.15–
4.67 
OSR (compared with EVAR) 
(missing = 0) 
1.99 0.97–
4.08 
0.06 1.76 0.75–
4.15 
Transportation to 
secondary hospital 
(missing = 0) 
0.63 0.36–
1.12 
0.11 0.59 0.30–
1.18 
Respiratory disease 
(missing = 28) 
2.11 1.10–
4.04 
0.02 1.95 0.95–
4.02 
First assessment by 
internist (compared with 
surgeon) (missing = 21) 
2.11 1.12–
4.00 
0.02 2.01 0.94–
4.28 
Previous heart condition 
(missing = 24) 
1.61 0.90–
2.90 
0.11   
Previous TIA/stroke 
(missing = 28) 
0.88 0.36–
2.19 
0.79   
Creatinine > 150 µmol/L 
(missing = 8) 
1.44 0.73–
2.84 
0.29   
Hypertension (missing = 51) 1.95 0.91–
4.20 
0.09   
First-recorded 
BP ≤ 90 mmHg (compared 
with > 90 mmHg) 
(missing = 2) 
1.08 0.60–
1.96 
0.79   
Reported syncope 
(missing = 0) 
0.91 0.53–
1.58 
0.75 
 
  
50
Abdominal	  Aortic	  Aneurysm	  
49	  	  
Study 3 
 
Altogether, 227 patients treated with open repair for rAAA were included 
in the study. Seventy-nine patients treated with primarily open abdomen 
after open repair at Sahlgrenska University hospital were compared to 
148 propensity score-matched controls treated at other vascular centres in 
Sweden. Medical records for control patients were retrieved after the 
propensity score matching. After review of these medical records, it was 
found that 40 (27%) of the patients in the control group were treated with 
open abdomen initiated at the primary operation. Thus, in the analysis, a 
cohort of patients who were all treated with a primary open abdomen was 
compared to a group where a clear majority (n = 108, 73%) were treated 
with a primary closed abdomen. There were no other differences in 
baseline data between the groups.  
 
There was no significant difference in mortality at 30 or 90 days, in need 
for renal replacement therapy, in frequency of bowel ischaemia, or in 
need for reoperation due to bleeding between the groups (Table 6). 
 
The adjusted odds ratio for mortality at 30 days was 0.66 (95% CI: 0.35‒
1.25) in patients treated with a primary open abdomen after open repair 
for rAAA at Sahlgrenska University Hospital (compared to the controls). 
Potential confounders that were adjusted for in the analysis were age, 
sex, perioperative bleeding > 5,000 ml, and creatinine > 150 mmol/l.  
 
Early graft infection occurred in 5.1% of the patients who were treated 
with open abdomen at Sahlgrenska University Hospital, as compared to 
2% in the control group (p = 0.24). 
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Table 6. Thirty-day mortality, need for postoperative haemodialysis, and 
intestinal ischaemia requiring bowel resection in patients treated with primary 
open abdomen at Sahlgrenska University Hospital, compared to propensity 
score-matched controls from other vascular centres in Sweden where open 
abdomen treatment was not a clinical routine (the abdomen was closed in 73% 
at the end of the primary procedure and left open in 27% of the control patients) 
 
rAAA, ruptured abdominal aortic aneurysm. 
 
 
Study 4 
 
Altogether, 455 patients seeking care in an emergency department for a 
confirmed rAAA were included in the study. Two hundred and forty-
eight patients underwent surgical intervention and 207 did not. At 
baseline, a systolic blood pressure of < 90 mmHg was more frequent in 
the correctly diagnosed group and the mean S-creatinine level was higher 
in the correctly diagnosed group. There were no significant differences 
between misdiagnosed patients and correctly diagnosed patients 
regarding mean age or the proportion of women.  
 
 
Patients treated for rAAA 
with a primary open 
abdomen at  
Sahlgrenska University 
Hospital 
n = 79 
Controls 
n = 148 
p 
Thirty-day mortality 21 (26.6%) 49 (33.1%) 0.37 
Ninety-day mortality 27 (34.2%) 54 (36.7%) 0.77 
Postoperative renal 
failure with need for renal 
replacement therapy 
25 (31.6%) 39 (26.4%) 0.44 
Postoperative intestinal 
ischaemia requiring 
bowel resection 
7 (8.9%) 21 (14.2%) 0.29 
 
Reoperation due to 
bleeding 
5 (6.3%) 22 (14.9%) 0.08 
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One hundred and seventy-seven (38.9%, 95% CI 34.4‒43.4%) were 
initially misdiagnosed.  An equal rate of misdiagnosis occurred in women 
and men. Misdiagnosis was more frequent in patients with a first-
recorded systolic blood pressure of > 90mmHg than in patients with a 
first-recorded systolic blood pressure of < 90mmHg (44.1% vs. 27.9%; 
p=001).  
 
Abdominal pain, back pain, and syncope were more frequently reported 
by patients who were correctly diagnosed. Vomiting and dyspnoea were 
more common symptoms in the misdiagnosed group. 
 
A higher mortality was found in patients who were initially misdiagnosed 
than in correctly diagnosed patients. When patients who were not offered 
surgical intervention after detection of a rAAA (palliative patients) were 
excluded, mortality remained significantly higher in misdiagnosed 
patients (Table 7). 
In multivariable logistic regression analysis adjusted for the potential 
confounders age, sex, first blood pressure < 90 mmHg, and the level of S-
creatinine, the risk of dying from rAAA was higher in misdiagnosed 
patients than in correctly diagnosed patients (OR 1.83, 95% CI: 1.13‒
2.96; p = 0.013) (Table 8). 
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Table 7. Mortality in patients who sought care for a ruptured abdominal 
aortic aneurysm, according to whether or not they were correctly 
diagnosed  
 
rAAA, ruptured abdominal aortic aneurysm. 
 
 
 
 
Table 8. Mortality in patients who sought care for a ruptured  
abdominal aortic aneurysm (n = 455) 
 
 
SBP, systolic blood pressure; CI, confidence interval. 
*Multivariable logistic regression analysis adjusted for misdiagnosis/correct  
diagnosis, age, sex, first-recorded blood pressure, and creatinine level. 
 
 
 
 
 Misdiagnosed 
group 
 
Correctly 
diagnosed 
group 
 
p 
Mortality in patients who sought care 
for rAAA (n = 455) 
132/177 
(74.6%) 
175/278 
(62.9%) 
0.01 
Mortality in rAAA patients, palliative 
patients excluded (n = 321) 
84/129  
(65.1%) 
89/192 
(46.4%) 
0.001 
 
 Odds ratio  
for crude  
rAAA 
mortality 
95% 
CI 
p-value Odds ratio 
for adjusted  
rAAA 
mortality* 
95% 
CI 
p-value 
Misdiagnosis 
 
1.73 1.14‒ 
2.62 
0.013 1.83 1.13‒
2.96 
0.013 
Age (per year) 
 
1.09 1.06‒
1.12 
< 0.0001 1.09 1.06‒
1.12 
< 0.0001 
Females 
 
1.99 1.25‒
3.16 
0.004 1.79 1.07‒
3.00 
0.03 
First-registered 
SBP 
≤ 90 mmHg 
 
1.13 0.74‒
1.74 
0.58 1.21 0.74‒
1.99 
0.45 
Creatinine (per 
mmol) 
1.00 1.00‒
1.01 
0.034 1.00 1.00‒
1.01 
0.03 
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Methodological considerations – limitations 
 
 
Selection bias 
 
In Study 1, all patients with screening-detected aneurysms registered in 
Swedvasc were compared to a matched control group. The risk of any 
selection bias in Study 1 was considered to be limited. 
 
In Study 3, the patients treated with a primary open abdomen at 
Sahlgrenska University Hospital were a selection of rAAA patients who 
were generally unsuitable for EVAR. Furthermore, stable patients with 
contained haematomas had the abdomen closed at the end of the primary 
procedure in the study period. Thus, the patients treated with open repair 
at Sahlgrenska University Hospital in Study 3 were a selection of 
patients with unfavourable aneurysm anatomy, a large amount of blood 
loss, and pronounced circulatory instability. Propensity score matching 
was used to create a control group resembling this selection as much as 
possible. However, it cannot be ruled out that there might be a remaining 
selection unaccounted for in the analysis.  
  
In Studies 2 and 4, there was a lower proportion of patients with a first-
recorded systolic blood pressure of < 90 mmHg in the misdiagnosis 
group than in the correct diagnosis group. This indicates that the 
misdiagnosis group was a selection of more haemodynamically stable 
patients. Such a selection would have the potential to dilute the result in 
these two studies, since it is likely that hypotension is associated with 
worse outcome. 
  
During Study 4, we identified patients who had undergone attempts at 
surgical intervention that were not registered in Swedvasc. This would 
introduce the possibility of selection bias in Study 2 (where all the 
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patients were identified in Swedvasc). It appears unlikely that such 
selection would be asymmetrically allocated to the misdiagnosis or 
correct diagnosis groups, so this probably did not contribute to selection 
bias. 
 
The autopsy rate was 11% in Sweden in 2016, according to the Swedish 
Cause of Death Registry. This number includes both clinical and forensic 
autopsies. The low frequency of autopsies might possibly have 
introduced bias in Study 4. There may have been patients who were 
misdiagnosed and sent home from the ED, and then died from rAAA. If 
no autopsy was performed in such cases, there would be a risk that the 
death would be classified as not being aneurysm-related in the Swedish 
Cause of Death Registry. Such patients would not have been identified 
and included in Study 4, despite seeking care in an ED for rAAA, since 
those who died from rAAA were identified in Study 4 by being coded as 
aortic aneurysm-related deaths in the Swedish Cause of Death Registry. 
It seems unlikely that this potential bias would be of such a magnitude 
that it would influence the result, but if this was the case, additional 
deaths would be added to the misdiagnosis group (but not to the correct 
diagnosis group). This would strengthen the result in Study 4 further. 
 
Information bias 
 
Registry studies always have a certain risk of bias due to erroneous 
registrations in the registry leading to misclassification. Mortality data 
are considered to be highly accurate, given the interconnection between 
Swedvasc and the Swedish population registry. Data regarding the type 
of procedure performed are unlikely to be erroneous. Registration of 
comorbidity and preoperative parameters in Swedvasc may be erroneous 
to a certain degree, given the acute character of the disease and the 
sometimes limited possibility of collecting these data. Swedvasc data 
regarding comorbidities and preoperative data were used in Studies 1, 2, 
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and 3.  Thus, there might be misclassification of confounders to some 
extent in these studies, but if present, misclassification is believed to be 
non-differential. The risk of misclassification of treatment or outcome is 
probably limited.  
Review of medical records has an inherent risk of misclassification. Most 
of the data collected by means of review of medical charts were checked 
by at least two independent observers in order to minimize this bias, and 
if present, it is believed to be limited and non-differential.  
Confounding 
 
Non-randomized observational studies always have a risk of 
confounding. In order to minimize this bias, multivariable logistic 
regression analysis was used in all studies in order to account for known 
confounders. In Study 3, propensity score matching was also used to 
minimize confounding. Still, there may have been unknown confounders 
and residual confounding that were unaccounted for in the analysis.  
Power 
 
It cannot be ruled out that parts of the results in Study 1 were the result 
of type-2 error due to lack of power. This bias was probably not present 
in Studies 2‒4. 
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Discussion	  
General discussion 
 
The principal aim of research regarding abdominal aortic aneurysms is to 
investigate possible ways of reducing mortality caused by rupture of the 
aneurysm. Ideally, some way of preventing the very emergence of an 
aneurysm―or at least growth of an existing aneurysm―would be the 
best approach to achieve this goal. Apart from risk factor modification 
such as reduction of smoking in the community, no efficient way to 
prevent aneurysm formation or growth is known. The aetiology of the 
disease is still too poorly understood to allow treatment or actions that 
would efficiently prevent aneurysm formation or growth in certain 
individuals. In the work that contributed to this thesis, we studied 
possible ways of reducing aneurysm-related mortality once an aneurysm 
has developed. The disease and the treatment of the disease were studied 
from three different angles representing three different parts of the course 
of the disease: surgical treatment before rupture, the assessment of 
patients suffering from a ruptured abdominal aortic aneurysm in the 
emergency department, and whether it would be possible to reduce the 
perioperative mortality in rAAA patients by leaving the abdomen open, 
with delayed closure, in those treated with open repair.  
 
Before rupture 
 
Since rupture of an abdominal aortic aneurysm carries a high mortality 
no matter what actions are taken by medical staff, it is obvious that it 
would be beneficial to find aneurysms before rupture, given the 
possibility of safe surgical treatment of large aneurysms in an elective 
setting. There is solid evidence from randomized controlled trials (RCTs) 
that screening for AAA reduces both AAA-related and all-cause 
mortality in elderly men119-123. However, at the time of Study 1, there 
were few published results on outcome after surgery on screening-
detected aneurysms under normal clinical circumstances (outside 
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randomized clinical trials). Prior to screening, most AAAs were detected 
coincidentally when imaging was performed in patients seeking care for a 
symptom. A patient cohort seeking care for a symptom could possibly be 
different from screened patients, since the very fact that they sought 
medical advice could indicate that they suffered from comorbidities to a 
greater degree.  
 
Screening was started locally in Sweden in 2006, and reached nationwide 
coverage in 201530. In 2010‒2013, the time period of Study 1, vascular 
surgeons were encountered by an increasing proportion of patients with 
AAAs detected by screening as compared to the previous standard patient 
with a coincidentally detected AAA. The contemporary results of 
surgical intervention for screening-detected aneurysms (compared to 
aneurysms that were not detected by screening) were not studied. 
Theoretically, AAA patients detected by screening could have less 
comorbidities and thus a better prognosis than AAA patients who are not 
detected by screening. It was also being debated which method of 
surgical intervention (open repair or EVAR) should be used in the 
relatively young AAA patients who are detected by screening. When 
considering surgical intervention, both the surgeon and the patient require 
better knowledge about the mortality and frequency of complications 
associated with the surgical intervention.  
 
In Study 1, population-based contemporary results of AAA surgery in 
Sweden were compared between screening-detected patients and age-
matched controls whose AAA was not detected by screening. It was 
found that mortality and the frequency of complications were low in both 
patient groups. No significant differences in mortality at 30 days or in the 
rate of complications were found between the groups. The 90-day 
mortality was higher in non screening-detected patients, and also with 
adjusted analysis. However, the mean age was 2 years older in the control 
group, which requires caution when interpreting the results. This 
difference had to be accepted in the matching procedure in order for us to 
have a sufficient number of control patients. Not allowing this range in 
age would have reduced the size of the cohorts and the power. 
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We hypothesized in Study 1 that screening-detected patients would have 
less comorbidity than patients with non screening-detected aneurysms. 
This could not be verified in the study, as the comorbidity profile was 
similar in the two groups. Despite this, open repair was used more 
frequently in screening-detected AAA patients (56%) than in those who 
were not detected by screening (45%) (p < 0.01). This might reflect a 
preconceived idea among surgeons that screening-detected patients have 
less comorbidity and are better fit for open surgery than patients who are 
not detected by screening, and that open surgery might be a better option, 
as lifelong surveillance after an EVAR is avoided.  
 
When Study 1 was carried out, all the data available on patients treated 
for screening-detected AAAs was used, but given the low mortality and 
the low rate of complications, the numbers of patients who died or 
suffered from severe complications were low in both groups. This is 
encouraging, but the low number of events limited the possibility of 
analysing potential differences between the groups and adjusting for 
confounders. It cannot be ruled out that the absence of differences 
between the groups (apart from 90-day mortality) can be explained by 
type-2 error due to lack of power. However, despite this, the data are 
important since the nationwide screening will probably make further 
comparisons between screening-detected and non-screening-detected 
patients impossible due to the lack of age-matched controls with 
aneurysms that are not detected by screening. The gradual 
implementation of the screening programme, which covered the years of 
Study 1, was a unique opportunity to compare screened and non-screened 
patients.  
 
To detect a significant difference of 0.8% (the difference in 30-day 
mortality between the groups), the study would have required a sample 
size of approximately 2,400 patients in each group. This number of age-
matched patients is not available.  
 
An important finding in this contemporary study was the low mortality in 
patients with screening-detected (0.6%) and non-screening-detected 
AAAs (1.4%). Subsequent studies of the nationwide results of AAA 
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screening in England and Sweden have also shown very low 
perioperative mortality rates (0.8‒0.9%)30,126, results that lend further 
support to AAA screening in elderly men.  
 
The declining prevalence of AAA and the reduced benefit associated 
with a lower prevalence―as well as the risk of overdiagnosis and 
potential psychological harm caused by screening―have been under 
debate in recent years127-129. The Swedish screening programme was 
judged to be highly cost-effective in the contemporary setting in a 
publication by Wanhainen et al. from 201630, in which it was also 
estimated that every fourth patient who has an AAA detected through 
screening would have a longer life as a result of attending the screening 
programme. A very recent meta-analysis of the long-term results in the 
four randomized screening trials showed that screening reduces both all-
cause mortality and AAA-related mortality123. 
 
Further research is required regarding potential psychological harm 
associated with detection of an AAA by screening. If the prevalence of 
AAAs continues to decline, follow-up of the cost-effectiveness of the 
screening programme is warranted.  
 
 
Rupture 
 
Intuitively, given the acute life-threatening character of ruptured 
abdominal aortic aneurysms, a rapid diagnosis in the emergency 
department would be of great importance. However, it is not always easy 
to make a correct diagnosis at the first assessment. Many physicians have 
encountered patients with rAAA who were initially misdiagnosed. The 
consequences of misdiagnosis of rAAA are largely unknown, and these 
were examined in Study 2 and Study 4 of this thesis.  
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Misdiagnosis 
 
In Study 2, the consequences of misdiagnosis of rAAA patients who 
reach surgery were investigated and in Study 4, patients with rAAA who 
did not reach surgery were also identified. The main results of these 
studies were that misdiagnosis is common and affects more than a third 
of the patients who seek treatment for rAAA in an emergency 
department. Misdiagnosis was not only common, it was also associated 
with a substantially higher mortality in patients with rAAA. In the subset 
of patients who reached surgery, no significant difference in mortality or 
in the rate of complications could be detected. In adjusted analysis, 
misdiagnosis remained a significant risk factor for mortality in the whole 
patient cohort, but not in the subset of patients who reached surgery. 
 
In both Study 2 and Study 4, a lower proportion of the misdiagnosed 
patients had a first-recorded SBP of < 90 mmHg. Empirically and also 
according to previous reports130-132, hypotension is a factor that is 
associated with an increased risk of dying in patients with rAAA. It 
would be expected that a cohort of patients where pronounced 
hypotension is less common would have a lower mortality than a cohort 
with a higher proportion of patients with pronounced hypotension. This 
was not the case in Study 2, where the misdiagnosed group with a lower 
proportion of hypotensive patients (12.8%) had a similar mortality to that 
of the correctly diagnosed group, in which 37.0% were hypotensive. It 
might be that the expected difference in mortality is counterbalanced by 
the misdiagnosis per se. It cannot be ruled out that the absence of any 
difference in mortality and complications between correctly diagnosed 
and misdiagnosed patients in Study 2 can be explained by selection of 
more stable patients in the misdiagnosis group. 
 
The frequency of misdiagnosis in Study 2 (33%) and Study 4 (38.9%) 
can be compared to that in previous heterogeneous studies, which found 
misdiagnosis rates of 25.6‒68%73,74,76-84. The rate of misdiagnosis in 
Study 2 and Study 4 was slightly lower than the overall rate of 42% 
reported in a review and meta-analysis by Azhar et al. in 2014, but was 
higher than the 32% in the subset of studies after 1990 that were reported 
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in the same review.  
 
For comparison, the frequency of misdiagnosis in the studies in this 
thesis was similar to or higher than those in previous reports on 
misdiagnosis in patients with aortic dissection (14.1‒39%)133-135 
 
The existing literature on how misdiagnosis affects outcome in rAAA 
patients is limited. To the best of my knowledge, four previous 
studies74,76,77,79 have compared mortality in misdiagnosed patients and in 
correctly diagnosed patients. In two of these studies 76,77, statistical 
analyses of the differences were not done. Akkersdijk et al. (n = 38) and 
Marston et al. (n = 152) compared mortality in misdiagnosed patients and 
correctly diagnosed patients, and no significant difference was found. 
However, no adjusted analysis to account for confounders was done in 
these studies.  
 
To the best of my knowledge, Study 4 is the largest study to investigate 
how misdiagnosis affects outcome in rAAA patients, and the first to 
analyse outcome in multivariable logistic regression to account for 
potential confounders.  
 
The high frequency of misdiagnosis and the associated higher mortality 
in misdiagnosed patients are important observations. Research in the field 
of vascular surgery is often focused on screening, methods and 
techniques at surgical intervention, and to some extent postoperative 
care. For instance, considerable resources have been used on randomized 
trials attempting to determine whether EVAR or open repair gives the 
best outcome in rAAA patients95,97,136,137. These studies have failed to 
demonstrate any clear benefit of either procedure. Investments are also 
being made worldwide in hybrid suites, in order to optimize the 
possibility of performing technically advanced endovascular procedures. 
Such investment may naturally have the potential to improve outcome in 
rAAA patients.  
 
However, the observed frequency of misdiagnosis and the significantly 
worse outcome in misdiagnosed patients in Study 4 tell us that the 
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importance of the basic clinical assessment in the emergency department 
must not be forgotten in this era of technical advancements in vascular 
surgery. A higher awareness of rAAA among emergency department 
staff and physicians is warranted, and further education about rAAA 
should be considered. 
 
 
Open abdomen treatment after open repair 
 
Leaving the abdomen open at the end of the procedure can eliminate the 
risk of development of abdominal compartment syndrome after open 
repair of an rAAA. Such a regimen would allow the possibility of 
avoiding the negative physiological effects of ACS, but might also 
increase the risk of complications such as infection and later abdominal 
hernia. Open abdomen treatment also requires resources for repeated 
redressing in an operating theatre. The rationale for Study 3 was to use 
the fact that Sahlgrenska University Hospital had accumulated a sample 
of patients treated with open abdomen after open rAAA repair, which 
was large in this context (n = 79). In order to minimize confounding as 
much as possible, a control group was constructed by propensity score 
matching in Swedvasc, and to further adjust for possible confounders and 
increase the robustness of the analysis, a multivariable logistic regression 
analysis was done.  
 
The main result of Study 3 was that there was no difference in mortality 
or in the frequency of major complications between the groups, using 
either crude or adjusted analysis. There were slightly more graft 
infections in the group treated with open abdomen at Sahlgrenska 
University Hospital than in the controls, but this difference was not 
statistically significant.  
 
The existing literature comparing treatment with a primary open 
abdomen and treatment with primary closure is very limited. A report by 
Acosta et al.138 has indicated that initiation of open abdomen treatment at 
the primary operation might be of value in patients who are treated for 
aortic disease with open or endovascular surgery. However, patients 
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treated with open abdomen initiated at the primary operation in that study 
were compared with patients who needed a secondary decompressive 
laparotomy, which requires caution in interpreting the results since 
patients who need a secondary decompressive laparotomy might 
constitute a selection of patients with poor outcome. A similar 
comparison was made in a study by Sörelius et al.116, where a subset of 
nine patients treated with open abdomen initially were compared with 21 
patients who underwent a secondary laparotomy/decompression. No 
significant difference in mortality was observed between the groups. 
Rasmussen et al. compared mortality in patients treated with open 
abdomen at the primary operation or after a decompressive 
laparotomy―since it was difficult to close the abdomen―with patients 
who had the abdomen closed initially, and found a higher mortality in 
patients treated with open abdomen 139. In the same study, no difference 
in mortality was seen when patients with open abdomen initially were 
compared with patients who needed a secondary decompressive 
laparotomy. Selection bias probably influenced the result in Rasmussen’s 
study, since it is likely that patients in whom it is difficult to close the 
abdomen have a worse prognosis than patients in whom the fascia can be 
sutured without tension. In a small series reported by Oelsclager et al. (n 
= 23), no difference in mortality was seen between patients with primary 
closure of the abdomen and those with delayed closure140. 
 
An important limitation of Study 3 was that 27% of the patients in the 
control group were treated with open abdomen (the treatment that the 
study was aimed to evaluate). A control group in which all the patients 
were treated with closed abdomen initially would obviously have been 
preferable. At the time of Study 3, it was not registered in Swedvasc 
whether or not patients were treated with open abdomen at the primary 
operation. Thus, this was found out after the propensity score matching 
was done and the medical records of the control group of patients were 
retrieved. We had expected that a small proportion of the patients in the 
control group would have been treated with a primary open abdomen. We 
did not foresee that treatment with a primary open abdomen would have 
been implemented to such a great extent (27%) in this subset of patients 
in Sweden. If primary open abdomen treatment were to be beneficial in 
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terms of mortality and complications, the 27% who were treated with 
open abdomen would dilute the result and possibly introduce type-2 
error.  
 
A randomized trial investigating whether primary open abdomen 
treatment or closure of the abdomen at the end of the primary procedure 
should be the treatment of choice after open repair for rAAA would be of 
great value. It is rather unlikely that such a study will ever be performed. 
In an era when EVAR is increasingly being used in rAAA patients, it 
would be demanding to arrange for a large enough sample in order to 
have sufficient power. Furthermore, surgeons would most probably be 
reluctant, and it would also be unethical to randomize patients where the 
abdomen cannot be closed without tension. This would exclude the 
selection of patients who are most likely to gain from primary open 
abdomen treatment.  
 
Study 3 compared a cohort of patients who were all treated with open 
abdomen after open repair for rAAA, with a cohort who were treated 
with closed abdomen in the majority of cases (73%). Apart from this, the 
groups were very similar in terms of known and potential confounders. 
Given the fact that it is unlikely that a randomized controlled study 
attempting to answer the question will ever be performed, the meagre 
knowledge on the topic, and the limited existing literature, I consider that 
the findings in Study 3 are important despite the fact that a minority of 
the patients in the control group were treated with a primary open 
abdomen. 
 
The study did not show a survival advantage or a difference in the 
frequency of major complications in patients treated with a primary open 
abdomen rather than a primary closed abdomen after open repair for 
rAAA. 
  
66
Abdominal	  Aortic	  Aneurysm	  
65	  	  
Conclusions 
• The contemporary postoperative mortality was low in a national audit of 
patients with AAA detected by screening and age-matched controls. 
• Patients with screening-detected AAAs had the same mortality and 
frequency of complications at 30 days as patients whose AAAs were not 
detected by screening. 
• Misdiagnosis is common in patients seeking care for rAAA, and it is 
associated with a substantially increased mortality. 
• No survival disadvantage or increased frequency of complications was 
observed in the subset of misdiagnosed rAAA patients who reached 
surgery.  
• We did not find that treatment with a primary open abdomen after open 
repair for rAAA was associated with a lower mortality or with a lower 
frequency of major complications, relative to a control group in which 
the majority of patients were treated with primary closure of the 
abdomen. Our findings do not support a regimen of routinely leaving the 
abdomen open at the end of the procedure after open repair for rAAA. 
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Future perspective 
Several areas in the field of AAA remain poorly investigated. 
•    It would be of value to investigate whether education regarding 
rAAA directed at emergency department staff and physicians 
would have the potential to reduce the frequency of 
misdiagnosis. A study comparing the frequency of misdiagnosis 
before and after a structured educational programme regarding 
rAAA, directed at emergency department staff and physicians, 
should be considered. 
•    A randomized controlled trial comparing primary closure of the 
abdomen in patients treated with open repair for rAAA would be 
desirable. Given the difficulties in performing such a study, it 
would be valuable to perform a cohort study comparing a group 
of patients to whom open abdomen treatment was given with a 
control group where all the patients had the abdomen closed.  
•   The possible psychological harm of being diagnosed with an 
AAA within a screening programme needs to be studied further. 
•    Further research investigating the reasons for the worse outcome 
of rAAA in women is warranted.  
•     Further research investigating the pathogenesis and aetiology of 
AAA, and possible ways of inhibiting the development or growth 
of an AAA, is clearly warranted.  
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